SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950116-04-000355
Filing Date
2004-02-03
Accepted
2004-02-03 13:31:50
Documents
1
Period of Report
2003-01-29
Items
Item 5: Other events

Document Format Files

Seq Description Document Type Size
1 8-K eight-k.htm 8-K 7978
  Complete submission text file 0000950116-04-000355.txt   9521
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25169 | Film No.: 04562025
SIC: 2834 Pharmaceutical Preparations